Close Menu

NEW YORK – Massachusetts General Hospital, the Infectious Disease Diagnostics Laboratory at Children's Hospital of Philadelphia (CHOP), and the Diagnostic Molecular Laboratory at Northwestern Medicine, have received Emergency Use Authorization from the US Food and Drug Administration for tests to detect SARS-CoV-2.

All three organization's real-time RT-PCR tests were cleared by the FDA last week for detecting  SARS-CoV-2 using nasopharyngeal swabs, nasal swabs, and bronchoalveolar lavage specimens.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

An Associated Press report says China refrained from releasing the SARS-CoV-2 genome for more than a week in January, frustrating the World Health Organization.

The Lancet and the New England Journal of Medicine have issued expressions of concern regarding the data used in two COVID-19 papers, the New York Times reports. 

Researchers have sequenced the genome of the mayfly, garnering insight into how insects evolved wings, Science reports.

In Genome Research this week: gene expression in primate brain regions, inversions and breakpoint inverted repeats in the human genome, and more.

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.